Rigel Pharmaceuticals enters collaboration and license agreement with Grifols
Rigel Pharmaceuticals announced it has entered into an exclusive license and supply agreement with Spain-based Grifols to commercialize fostamatinib disodium hexahydrate in all potential indications in Europe and Turkey. January 23, 2019